William L. Gerald
#140,349
Most Influential Person Now
William L. Gerald's AcademicInfluence.com Rankings
William L. Geraldbiology Degrees
Biology
#9914
World Rank
#13180
Historical Rank
Computational Biology
#195
World Rank
#196
Historical Rank
Genetics
#1028
World Rank
#1126
Historical Rank
Download Badge
Biology
William L. Gerald's Degrees
- PhD Genetics Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is William L. Gerald Influential?
(Suggest an Edit or Addition)William L. Gerald's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) (5775)
- Integrative genomic profiling of human prostate cancer. (2010) (3312)
- Genes that mediate breast cancer metastasis to lung (2005) (2922)
- Multiclass cancer diagnosis using tumor gene expression signatures (2001) (2107)
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis (2005) (1923)
- Endogenous human microRNAs that suppress breast cancer metastasis (2008) (1889)
- Genes that mediate breast cancer metastasis to the brain (2009) (1647)
- MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib (2007) (1619)
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study (2008) (1063)
- Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (2001) (990)
- Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts (1999) (963)
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4 (2008) (897)
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases (2011) (833)
- MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells (2001) (789)
- Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. (2005) (702)
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (2009) (666)
- Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. (2007) (636)
- Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. (2004) (590)
- Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control (2004) (564)
- Intra‐abdominal Desmoplastic Small Round‐Cell Tumor: Report of 19 Cases of a Distinctive Type of High‐Grade Polyphenotypic Malignancy Affecting Young Individuals (1991) (557)
- Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. (2005) (549)
- WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis (2009) (545)
- An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen (2006) (537)
- Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. (2002) (524)
- Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. (1998) (511)
- Gene expression profiling predicts clinical outcome of prostate cancer. (2004) (506)
- Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. (1994) (492)
- EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. (1998) (484)
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis (2009) (481)
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer (2008) (453)
- Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. (2008) (429)
- Expression of TERT in early premalignant lesions and a subset of cells in normal tissues (1998) (404)
- Solitary Fibrous Tumor Consistent CD34 Immunoreactivity and Occurrence in the Orbit (1994) (391)
- Case 2. Desmoplastic small cell tumor with divergent differentiation. (1989) (384)
- Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. (1998) (378)
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer (2009) (361)
- Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis (2008) (359)
- EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations (2005) (347)
- Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. (2000) (339)
- Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer (2009) (339)
- Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. (1996) (332)
- The role of SPINK1 in ETS rearrangement-negative prostate cancers. (2008) (327)
- An X Chromosome Gene, WTX, Is Commonly Inactivated in Wilms Tumor (2007) (326)
- The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin (1999) (322)
- Epigenetic lesions at the H19 locus in Wilms' tumour patients (1994) (321)
- A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer (2006) (311)
- Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. (1995) (293)
- Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. (2004) (270)
- TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. (2009) (267)
- Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. (2003) (266)
- ID genes mediate tumor reinitiation during breast cancer lung metastasis (2007) (264)
- Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling (2011) (263)
- Relationship of gene expression and chromosomal abnormalities in colorectal cancer. (2006) (262)
- A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies (2006) (260)
- Expression of c-kit and kit ligand proteins in normal human tissues. (1994) (257)
- The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers (2009) (257)
- Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. (2004) (256)
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer (2010) (254)
- Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. (2009) (253)
- Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer (2007) (251)
- Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. (2006) (225)
- An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors (2009) (223)
- Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer (2007) (215)
- A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. (1998) (215)
- Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. (1995) (214)
- Value of Histopathology in Predicting Microsatellite Instability in Hereditary Nonpolyposis Colorectal Cancer and Sporadic Colorectal Cancer (2003) (209)
- Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer (2009) (196)
- Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. (2006) (193)
- WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin (2001) (177)
- Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. (1998) (176)
- High expression of the Met receptor in prostate cancer metastasis to bone. (2002) (176)
- Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. (2005) (173)
- Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy (2005) (173)
- NF-kappaB regulates androgen receptor expression and prostate cancer growth. (2009) (171)
- Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. (1994) (170)
- Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence (2003) (169)
- Constitutively Activated Stat3 Induces Tumorigenesis and Enhances Cell Motility of Prostate Epithelial Cells through Integrin β6 (2007) (162)
- Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. (1995) (160)
- The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour (1997) (159)
- Desmoid fibromatosis is a clonal process. (1996) (158)
- Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer (2006) (158)
- Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. (2011) (156)
- EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. (2005) (154)
- Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. (1995) (153)
- Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study (2005) (153)
- Value of Immunohistochemical Detection of DNA Mismatch Repair Proteins in Predicting Germline Mutation in Hereditary Colorectal Neoplasms (2005) (153)
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development (2010) (145)
- Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay. (1995) (136)
- A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer (2013) (135)
- Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. (2008) (134)
- Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. (2004) (132)
- Lrf suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion (2013) (128)
- Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. (2008) (125)
- Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults. (2006) (121)
- Desmoplastic small round cell tumor of the pleura. (1995) (120)
- HER 2/neu expression and gene amplification in colon cancer (2003) (115)
- N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. (2001) (114)
- The EWS-WT1 gene fusion in desmoplastic small round cell tumor. (2005) (112)
- Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8. (2007) (112)
- Identification of DOK genes as lung tumor suppressors (2010) (111)
- KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. (2008) (111)
- Identifying site-specific metastasis genes and functions. (2005) (110)
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features (2010) (108)
- Intracranial desmoplastic small-cell tumor. Report of a case. (1996) (107)
- Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. (1996) (106)
- Identification of novel androgen receptor target genes in prostate cancer (2007) (103)
- Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. (1997) (102)
- Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. (2000) (101)
- 18F-FDG PET of Locally Invasive Breast Cancer and Association of Estrogen Receptor Status with Standardized Uptake Value: Microarray and Immunohistochemical Analysis (2010) (96)
- Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha. (2007) (93)
- Clinicopathologic Features of Rhabdomyosarcoma of Gynecologic Origin in Adults (2007) (92)
- MDM2 and CDK4 gene amplification in Ewing's sarcoma (1995) (91)
- Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy (2007) (88)
- Molecular Variants of the EWS‐WT1 Gene Fusion in Desmoplastic Small Round Cell Tumor (1998) (88)
- Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. (2001) (87)
- Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications. (1989) (86)
- Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. (2006) (85)
- Biobanking of Human Pancreas Cancer Tissue: Impact of Ex-Vivo Procurement Times on RNA Quality (2010) (85)
- Utilization of Bone Marrow-Derived Endothelial Cell Precursors in Spontaneous Prostate Tumors Varies with Tumor Grade (2004) (84)
- MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors (2011) (82)
- MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas (2011) (82)
- Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma. (1998) (81)
- Desmoplastic small round cell tumors: Prognostic indicators and results of surgical management (1998) (78)
- Primary desmoplastic small cell tumor of soft tissues and bone of the hand. (1999) (77)
- Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. (2002) (77)
- Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. (2003) (77)
- The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. (2005) (77)
- Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. (2005) (75)
- The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. (2008) (75)
- Irinotecan for Pediatric Solid Tumors: The Memorial Sloan-Kettering Experience (2002) (73)
- Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression. (2006) (72)
- High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. (1998) (70)
- Malignant vascular tumors in young patients (1998) (70)
- Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma (2008) (70)
- A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers (2006) (70)
- Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling (2009) (68)
- Differential p53-Independent Outcomes of p19Arf Loss in Oncogenesis (2009) (68)
- GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1 (2006) (67)
- Stat3 Mediates Expression of Autotaxin in Breast Cancer (2011) (67)
- Gene expression profiling in single cells within tissue (2005) (60)
- Copy number and gene expression differences between African American and Caucasian American prostate cancer (2010) (60)
- Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA. (2009) (59)
- Biological behavior of human breast cancer micrometastases. (2001) (59)
- Pediatric rhabdomyosarcoma of the head and neck. (1997) (58)
- Transcriptional Activation of Placental Growth Factor by the Forkhead/Winged Helix Transcription Factor FoxD1 (2003) (57)
- Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. (2000) (57)
- Phosphorylation of the Androgen Receptor by PIM1 in Hormone Refractory Prostate Cancer (2012) (57)
- Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. (2001) (56)
- Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience. (1998) (55)
- Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations (2008) (54)
- Immunological identification of rat tissue kallikrein cDNA and characterization of the kallikrein gene family. (1986) (53)
- Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein. (2003) (53)
- MDM2 Gene Amplification Is Correlated to Tumor Progression but not to the Presence of SNP309 or TP53 Mutational Status in Primary Colorectal Cancers (2008) (53)
- Microarray analysis of prostate cancer progression to reduced androgen dependence: Studies in unique models contrasts early and late molecular events (2004) (53)
- Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor. (2002) (52)
- The signatures of autozygosity among patients with colorectal cancer. (2008) (51)
- Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa (2006) (51)
- International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. (1996) (49)
- Desmoplastic small cell tumor with multi-phenotypic differentiation. (1993) (49)
- Viral gene detection in oral neoplasms using the polymerase chain reaction. (1993) (48)
- Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. (1996) (47)
- Expression profiling of human tumors: the end of surgical pathology? (2001) (47)
- Induction of the interleukin-2/15 receptor β-chain by the EWS–WT1 translocation product (2002) (46)
- Desmoplastic Small Cell Tumor in the Pancreas (2004) (46)
- ETS rearrangements and prostate cancer initiation (2009) (45)
- Genetic heterogeneity and clonal evolution in neuroblastoma (2001) (44)
- Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70. (2008) (44)
- Adenosine Transporter ENT4 Is a Direct Target of EWS/WT1 Translocation Product and Is Highly Expressed in Desmoplastic Small Round Cell Tumor (2008) (44)
- The RET oncogene is a critical component of transcriptional programs associated with retinoic acid–induced differentiation in neuroblastoma (2007) (41)
- Origin of neuroblastic tumors: clues for future therapeutics (2004) (40)
- Analysis of p21WAF1/CIP1 in primary bladder tumors. (1998) (38)
- Novel mutations of epidermal growth factor receptor in localized prostate cancer. (2006) (37)
- Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. (2004) (37)
- Sex dimorphism and hormonal regulation of rat tissue kallikrein mRNA. (1986) (35)
- Chest wall rhabdomyosarcoma (1997) (34)
- Characterization of a cell line derived from rhabdoid tumor of kidney. (1991) (33)
- Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. (1992) (32)
- Clinically critical impact of molecular genetic studies in pediatric solid tumors. (1999) (32)
- Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma (2009) (31)
- Unusual postirradiation sarcoma of chest wall (1976) (31)
- Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers. (1997) (30)
- Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis. (1999) (29)
- Kinetics of primary tumor regression with chemotherapy: Implications for the timing of surgery (1996) (29)
- Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma. (1997) (28)
- Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3 (2010) (28)
- Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma. (2003) (27)
- Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. (2009) (27)
- Immunohistochemical Detection of Cathepsin D in T2N0M0 Breast Carcinoma (1994) (27)
- Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. (2007) (27)
- Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. (2007) (25)
- Activator of Transcription 3 Transformation by Activated Signal Transducer and Cyclin D 1 Is Transcriptionally Regulated by and Required for Updated (2006) (24)
- Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease (2001) (24)
- Apaf-1 expression in malignant melanoma (2006) (23)
- Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis (2009) (22)
- Evolving significance of prognostic markers associated with treatment improvement in patients with Stage 4 neuroblastoma (2002) (22)
- Desmoplastic small round cell tumour of unknown primary origin with lymph node and lung metastases: histological, cytological, ultrastructural, cytogenetic and molecular findings (1998) (21)
- Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma. (2002) (21)
- Expression of androgen receptor and its phosphorylated forms in breast cancer progression (2013) (20)
- A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (2002) (18)
- LETTER TO THE EDITOR. SPECIFICITY OF THE EWS/WT1 GENE FUSION FOR DESMOPLASTIC SMALL ROUND CELL TUMOUR (1996) (18)
- Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma. (2001) (18)
- Prognostic value of MYCN and ID2 overexpression in neuroblastoma (2005) (18)
- Desmoplastic Small Round-Cell Tumor: A Recently Recognized Tumor Type Associated with a Unique Gene Fusion (1995) (17)
- Congenital mesoblastic nephroma with metastasis to the brain: a case report. (1994) (16)
- Identification of MYCN Gene Amplification in Neuroblastoma Using Chromogenic In Situ Hybridization (CISH): An Alternative and Practical Method (2005) (16)
- A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies (2007) (15)
- Elevated expression of VEGFR-2 and VEGFA in desmoplastic small round cell tumor (DSRCT) and activity of bevacizumab and irinotecan in a xenograft model of DSRCT. (2009) (15)
- Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations. (2000) (15)
- Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma. (1996) (15)
- Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience. (2001) (14)
- Reassessment of Id 1 Protein Expression in Human Mammary , Prostate , and Bladder Cancers Using a Monospecific Rabbit Monoclonal Anti-Id 1 Antibody (2006) (14)
- Genomic medicine and neuroblastoma (2003) (14)
- Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status (2008) (14)
- Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery. (2008) (14)
- PINK1-Parkin pathway (2014) (14)
- Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21–23 in the biology of favourable stage 4 tumours (2004) (13)
- A Practical Approach to the Differential Diagnosis of Small Round Cell Tumors of Infancy Using Recent Scientific and Technical Advances (2000) (13)
- Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. (2001) (13)
- Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma (2007) (13)
- Insulin-like growth factor production by childhood solid tumors. (1991) (12)
- Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography. (2008) (12)
- Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique. (2003) (12)
- Monoclonal antibody to human Trk-A: diagnostic and therapeutic potential in neuroblastoma. (1997) (11)
- MDM2 expression and regulation in prostate cancer racial disparity. (2009) (11)
- The Role of MicroRNAs in Human Prostate Cancer (2010) (11)
- Expression Profiling of Human Tumors (2003) (10)
- Leiomyosarcoma in childhood and adolescence (1997) (8)
- Comparison of normal and tumor cells by laser capture microdissection. (2002) (7)
- KLF 6-SV 1 overexpression accelerates human and mouse prostate cancer progression and metastasis (2018) (6)
- Erratum: Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway (Proceedings of the National Academy of Sciences of the United States of America) (September 27, 2005) 102 (13909-13914) DOI: 10.1073/pnas.0506517102)) (2006) (6)
- Human Cancer Biology PIK 3 CA Mutation Associates with Improved Outcome in Breast Cancer (2009) (6)
- Expression of a DNA replication gene cluster in bacteriophage T4: genetic linkage and the control of gene product interactions. (1984) (6)
- The molecular genetics of Wilms tumor: a paradigm of heterogeneity in tumor development. (1994) (6)
- Correction: Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis (2014) (5)
- Genome-wide gene expression analysis of prostate carcinoma. (2003) (5)
- Gene Expression Analysis of Prostate Carcinoma (2003) (4)
- Active kallikrein, preprokallikrein, and kallikrein-inhibitor complex. (1986) (4)
- Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids (1995) (4)
- Cancer Xenograft Model CWR 22-R Nonresponsive Genes in the Androgen-independent Prostate Dysregulated Expression of Androgen-responsive and Updated Version (2000) (3)
- Characterization of rat kallikrein-like multigene family and its expression in the submandibular gland. (1986) (3)
- Mutations and Prognosis in Breast Cancer Androgen Receptor Levels and Association with PIK 3 CA (2009) (3)
- The immunologic approach to analysis of malignant lymphoma. Mantle zone lymphoma of the ileocecal region. (1987) (3)
- Use of the Notch signaling pathway to predict disease progression and distant recurrence-free survival in early stage colon cancer (2008) (2)
- Different chromosomal alterations correlate with gene expression in African American (AA) versus Caucasian American (CA) prostate cancer (PC) patients (2007) (2)
- Specific gene expression profiles and unique chromosomal abnormalities are associated with regressing tumors among infants with disseminated neuroblastoma (2007) (2)
- CONTROL OF TRANSLATION BY THE REG A GENE OF T4 BACTERIOPHAGE (1982) (2)
- 1430: Association of Cysteine-Rich Secretory Protein 3 and Beta-Microseminoprotein with Outcome after Radical Prostatectomy: Evaluation with a Tissue Microarray of 947 Primary Prostate Cancers (2007) (2)
- Abstract 662: Molecular characterisation ofERG,ETV-1andPTEN- gene loci identifies patients at low and high risk of death from prostate cancer (2010) (2)
- Re-identification of Affymetrix HG-U133 probe sequences using BLAST alignment and its application to distinguishing lung cancer from normal lung expression profiles (2006) (1)
- Expression of LATS2 and STK17B distinguishes epidermal growth factor receptor (EGFR) gene mutations in exons 19 and 21 from those in 18 and 20 in lung adenocarcinomas (2011) (1)
- Integrated genomic analysis of lung adenocarcinomas identifies loss of the MAPK phosphatase gene DUSP4 in most EGFR mutant tumors (2007) (1)
- Introduction: Present and Potential Impact of Expression Profiling Studies of Human Tumors (2003) (1)
- O-078 Gene expression profiling of malignant mesothelioma forprognostic prediction and identification of potential therapeutic targets and differential diagnostic markers (2005) (1)
- Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer (2020) (1)
- Distinct PIK3CA mutation profiles in estrogen receptor (ER) negative breast cancer (BC) subsets. (2006) (1)
- Analysis of Neuroblastoma Novel Regions of Allelic Imbalance Identified by Genome-wide Updated Version (2002) (1)
- ABERRANT ERG EXPRESSION COOPERATES WITH PTEN LOSS TO PROMOTE PROSTATE TUMORIGENESIS (2008) (1)
- The 2006 Fred Waldorf Stewart Award Recipient Juan Rosai, MD (2007) (1)
- Loss of Heterozygosity at 19 q 13 . 3 Is Associated with Locally Aggressive Neuroblastoma 1 (2001) (1)
- Microarray analyses reveals “what’s up” in human neuroblastoma malignant stem cells (2006) (1)
- Adenosine Transporter ENT 4 Is a Direct Target of EWS / WT 1 Translocation Product and Is Highly Expressed in Desmoplastic Small Round Cell Tumor (2008) (1)
- Abstract 2405: Identification of PHLPP as a tumour suppressor reveals the role of pathway feedback compensation in PTEN-mutant prostate cancer progression (2011) (1)
- Ki-67 is an independent predictor of outcome in conservatively treated clinically localised prostate cancer (2008) (1)
- Molecular Pathology of Neuroblastic Tumors Based on Genome-wide Expression Analysis (2005) (1)
- 818: Protein Expression Profiles for JAG-1 and NFK-B Suggest Converging Roles in Prostate Cancer Progression (2006) (1)
- Distinct Patterns of Loss of Heterozygosity (LOH) on Chromosome 1p Distinguish Spontaneous-Remitting Stage 4s from Lethal Stage 4 Disseminated Infant Neuroblastoma (1999) (0)
- 285: The Impact of Socioeconomic Factors on Prostate Cancer Outcomes in a Large Series of African-American Patients (2007) (0)
- HDM2 overexpression and promoter polymorphism (SNP309) genotype: Comparison between African American (AA) and Caucasian American (CA) prostate cancer patients (pts) (2008) (0)
- Inhibition of NF-κB decreases androgen receptor expression and prostate cancer growth (2006) (0)
- Molecular B iology o f t he E wing's S arcoma/Primitiv e Neuroectodermal T umor F amily (2000) (0)
- Identification of candidate tumor related genes using comprehensive gene expression analysis of neuroblastic tumors. (2006) (0)
- 788: Microarray-Based Nomogram for Disease Recurrence After Radical Prostatectomy: Combining Gene Expression Information with Clinical Variables to Enhance Predictive Accuracy (2004) (0)
- Prostate Cancer Cells clone-27 Loss on Androgen-Regulated Transcription in Genome-Wide Impact of Androgen Receptor Trapped (2012) (0)
- Abstract 2879: Mechanisms of integration for androgen receptor and phosphatidylinositol 3-kinase signaling in estrogen receptor negative class A breast cancer (2011) (0)
- KLF6-SV1 accelerates prostate cancer progression and metastasis (2008) (0)
- Diganglioside GD2 and Antigen 8H9: Potential Targets for Antibody-Based Immunotherapy against Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma (1999) (0)
- Abstract A70: Oncogenic potential of multiple splicing isoforms of the prostate‐cancer specific TMPRSS2‐ERG gene fusion product (2009) (0)
- 1401 ORAL The biological basis of ploidy as a genetic marker for the distinct clinical behaviour of neuroblastic tumours (2007) (0)
- IS097 Keynote Lecture : Signaling Events in Cardiomyocyte Dropout (2000) (0)
- High expression of the chemokine receptor CXCR4 is associated with estrogen receptor-negative breast cancer. (2006) (0)
- Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer (2020) (0)
- Syne1 Promoter Hypermethylation as a Predictor of Tumor Aggressiveness in Primary Breast Cancer (2008) (0)
- The chimeric EWS-WT1 gene product in the desmoplastic small round cell tumor: Molecular detection and alternative transcripts (1994) (0)
- Clonal heterogeneity and evolution of tumor DNA ploidy in neuroblastoma (NB) presenting as local-regional (LR) disease (2000) (0)
- Gene expession prolifing of large cell neuroendocrine carcinoma (LCNEC): PD1-3-6 (2007) (0)
- Gene Expression Analysis of Breast Cancer Progression (2005) (0)
- αSGT: A critical determinant of androgen receptor function in prostate cancer (2006) (0)
- Short Communication Detection ofChimeric Transcripts in Desmoplastic SmallRoundCell Tumorand Related Developmental TumorsbyReverse Transcriptase Polymerase ChainReaction ASpecific Diagnostic Assay (1995) (0)
- Pulmonary Neuroendocrine (NE) tumors: a 15-year retrospective clinicopathologic study of 317 cases: P1-173 (2007) (0)
- Monospecific Rabbit Monoclonal Anti-Id 1 Antibody Mammary , Prostate , and Bladder Cancers Using a Reassessment of Id 1 Protein Expression in Human (2006) (0)
- Understanding the Mitochondrial Dynamism-Mitophagy-Apoptosis Interactome (2014) (0)
- Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. (2023) (0)
- #662 Taxol induces wide-spread necrosis in rhabdomyosarcoma (1997) (0)
- A lung adenocarcinoma subset associated with non-smokers, micropapillary architecture, distinct transcript profile, and EGFR mutation (2006) (0)
- A103 andT311: two new monoclonal antibodies against the Melan-A (MART-1) and tyrosinase antigens for use on formalin-fixed paraffin-embedded tissues (1997) (0)
- PIK3CA and AKT1 mutations are independent in invasive breast cancer. (2009) (0)
- Gene expression profiling of neuroblastoma: Analysis of nonmetastatic versus metastatic tumors. (2004) (0)
- 911 PREDICTION OF OUTCOME AFTER RADICAL PROSTATECTOMY USING A TISSUE MICROARRAY OF 947 PRIMARY PROSTATE CANCERS AND IMMUNOHISTOCHEMICAL DETECTION OF CYSTEINE-RICH SECRETORY PROTEIN 3 (CRISP-3) AND BETA-MICROSEMINOPROTEIN (MSP) (2007) (0)
- Memorial Sloan-Kettering Cancer Center The 20th Annual Course on the Surgical Pathology of Neoplastic Diseases (1997) (0)
- Comment: Duplication of the Fusion of TMPRSS2 to ERG Sequences Identifies Fatal Human Prostate Cancer (2008) (0)
- Testing and Validating High Throughput Genomic Analysis of FFPE Samples: Systematic Gene Expression Differences between Matched Frozen and FFPE Samples Due to Rapid mRNA Degradation Signals (2011) (0)
- Colorectal Cancer The Signatures of Autozygosity among Patients with Updated (2008) (0)
- State-of-the-Art : Molecular Determinants of Apoptotic Remodeling in Pathological Hypertrophy (2003) (0)
- Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William L. Gerald?
William L. Gerald is affiliated with the following schools:
